Literature DB >> 20024046

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

Jason P Gleghorn1, Erica D Pratt, Denise Denning, He Liu, Neil H Bander, Scott T Tagawa, David M Nanus, Paraskevi A Giannakakou, Brian J Kirby.   

Abstract

Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20024046      PMCID： PMC3031459          DOI： 10.1039/b917959c

Source DB:  PubMed          Journal:  Lab Chip        ISSN： 1473-0189            Impact factor:   6.799


  15 in total

1.  Continuous particle separation through deterministic lateral displacement.

Authors:  Lotien Richard Huang; Edward C Cox; Robert H Austin; James C Sturm
Journal:  Science       Date:  2004-05-14       Impact factor: 47.728

2.  Effect of disorder on DNA electrophoresis in a microfluidic array of obstacles.

Authors:  Aruna Mohan; Patrick S Doyle
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2007-10-24

3.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Authors:  S S Chang; V E Reuter; W D Heston; N H Bander; L S Grauer; P B Gaudin
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

4.  Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

Authors:  W Jeffrey Allard; Jeri Matera; M Craig Miller; Madeline Repollet; Mark C Connelly; Chandra Rao; Arjan G J Tibbe; Jonathan W Uhr; Leon W M M Terstappen
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

5.  Detection and characterization of carcinoma cells in the blood.

Authors:  E Racila; D Euhus; A J Weiss; C Rao; J McConnell; L W Terstappen; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

6.  Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

Authors:  Howard I Scher; Xiaoyu Jia; Johann S de Bono; Martin Fleisher; Kenneth J Pienta; Derek Raghavan; Glenn Heller
Journal:  Lancet Oncol       Date:  2009-02-11       Impact factor: 41.316

7.  Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Authors:  Sunitha Nagrath; Lecia V Sequist; Shyamala Maheswaran; Daphne W Bell; Daniel Irimia; Lindsey Ulkus; Matthew R Smith; Eunice L Kwak; Subba Digumarthy; Alona Muzikansky; Paula Ryan; Ulysses J Balis; Ronald G Tompkins; Daniel A Haber; Mehmet Toner
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

8.  Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.

Authors:  Siyang Zheng; Henry Lin; Jing-Quan Liu; Marija Balic; Ram Datar; Richard J Cote; Yu-Chong Tai
Journal:  J Chromatogr A       Date:  2007-05-29       Impact factor: 4.759

9.  Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor.

Authors:  André A Adams; Paul I Okagbare; Juan Feng; Matuesz L Hupert; Don Patterson; Jost Göttert; Robin L McCarley; Dimitris Nikitopoulos; Michael C Murphy; Steven A Soper
Journal:  J Am Chem Soc       Date:  2008-06-17       Impact factor: 15.419

10.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531
View more
  130 in total

1.  Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.

Authors:  Steven M Santana; He Liu; Neil H Bander; Jason P Gleghorn; Brian J Kirby
Journal:  Biomed Microdevices       Date:  2012-04       Impact factor: 2.838

2.  Antibody-functionalized fluid-permeable surfaces for rolling cell capture at high flow rates.

Authors:  Sukant Mittal; Ian Y Wong; William M Deen; Mehmet Toner
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

Review 3.  Isolated, disseminated and circulating tumour cells in prostate cancer.

Authors:  David Schilling; Tilman Todenhöfer; Jörg Hennenlotter; Christian Schwentner; Tanja Fehm; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2012-07-10       Impact factor: 14.432

Review 4.  Alternating current electrohydrodynamics in microsystems: Pushing biomolecules and cells around on surfaces.

Authors:  Ramanathan Vaidyanathan; Shuvashis Dey; Laura G Carrascosa; Muhammad J A Shiddiky; Matt Trau
Journal:  Biomicrofluidics       Date:  2015-12-08       Impact factor: 2.800

5.  An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.

Authors:  Siyang Li; Brian D Plouffe; Arseniy M Belov; Somak Ray; Xianzhe Wang; Shashi K Murthy; Barry L Karger; Alexander R Ivanov
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

6.  Surface Functionalized Graphene Biosensor on Sapphire for Cancer Cell Detection.

Authors:  Daniel J Joe; Jeonghyun Hwang; Christelle Johnson; Ho-Young Cha; Jo-Won Lee; Xiling Shen; Michael G Spencer; Sandip Tiwari; Moonkyung Kim
Journal:  J Nanosci Nanotechnol       Date:  2016-01

Review 7.  Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

Authors:  Joshua M Jackson; Małgorzata A Witek; Joyce W Kamande; Steven A Soper
Journal:  Chem Soc Rev       Date:  2017-07-17       Impact factor: 54.564

Review 8.  Microfluidic sample preparation for diagnostic cytopathology.

Authors:  Albert J Mach; Oladunni B Adeyiga; Dino Di Carlo
Journal:  Lab Chip       Date:  2013-03-21       Impact factor: 6.799

Review 9.  NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.

Authors:  Yu Jen Jan; Jie-Fu Chen; Yazhen Zhu; Yi-Tsung Lu; Szu Hao Chen; Howard Chung; Matthew Smalley; Yen-Wen Huang; Jiantong Dong; Li-Ching Chen; Hsiao-Hua Yu; James S Tomlinson; Shuang Hou; Vatche G Agopian; Edwin M Posadas; Hsian-Rong Tseng
Journal:  Adv Drug Deliv Rev       Date:  2018-03-15       Impact factor: 15.470

10.  Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures.

Authors:  Shuang Hou; Haichao Zhao; Libo Zhao; Qinglin Shen; Kevin S Wei; Daniel Y Suh; Aiko Nakao; Mitch A Garcia; Min Song; Tom Lee; Bin Xiong; Shyh-Chyang Luo; Hsian-Rong Tseng; Hsiao-hua Yu
Journal:  Adv Mater       Date:  2012-12-17       Impact factor: 30.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.